2022
DOI: 10.3389/fneur.2022.946431
|View full text |Cite
|
Sign up to set email alerts
|

Remote ischemic conditioning for acute ischemic stroke part 2: Study protocol for a randomized controlled trial

Abstract: BackgroundRemote ischemic conditioning (RIC) refers to the application of repeated short periods of ischemia intended to protect remote areas against tissue damage during and after prolonged ischemia.AimWe aim to evaluate the efficacy of RIC, determined by the modified Rankin Scale (mRS) score at 90 days after stroke onset.Design and methodsThis study is an investigator-initiated, multicenter, prospective, randomized, open-label, parallel-group clinical trial. The sample size is 400, comprising 200 patients wh… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(2 citation statements)
references
References 40 publications
0
2
0
Order By: Relevance
“…The main endpoint events are safety and incidence of adverse events, and the secondary result is prognosis. A Japanese study is currently underway on the effectiveness of RIC in treating AIS patients within 48 h of symptom onset 36 . The primary outcome will be evaluated by the mRS score 90 days after stroke onset.…”
Section: Clinical Application Of Ric In Strokementioning
confidence: 99%
See 1 more Smart Citation
“…The main endpoint events are safety and incidence of adverse events, and the secondary result is prognosis. A Japanese study is currently underway on the effectiveness of RIC in treating AIS patients within 48 h of symptom onset 36 . The primary outcome will be evaluated by the mRS score 90 days after stroke onset.…”
Section: Clinical Application Of Ric In Strokementioning
confidence: 99%
“…A Japanese study is currently underway on the effectiveness of RIC in treating AIS patients within 48 h of symptom onset. 36 The primary outcome will be evaluated by the mRS score 90 days after stroke onset. In the future, more large‐scale multicenter trials are needed to prove the optimal time window and the most effective application regimen of RIC treatment in patients with AIS, and it is necessary to confirm the brain‐protective effect of RIC treatment in patients with AIS by different metrics such as imaging or blood markers.…”
Section: Clinical Application Of Ric In Strokementioning
confidence: 99%